|
|
|
|
A more recent version of this article appeared on November 1, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 27, 2007
Revised on August 21, 2007
Accepted on August 29, 2007



*Department of Biochemistry and Molecular Biology,
Aging-associated Vascular Disease Research Center, and
Department of Pathology, College of Medicine, Yeungnam University, Daegu 705-717, Republic of Korea;
Department of Microbiology, College of Natural Science, Kyungpook National University, Daegu 702-701, Republic of Korea
Monitoring Editor: Carl-Henrik Heldin
The insulin-like growth factor (IGF) signaling pathway plays a crucial role in the regulation of cell growth, differentiation, apoptosis and aging. IGF binding proteins (IGFBPs) are important members of the IGF axis. IGFBP-5 is up-regulated during cellular senescence in human dermal fibroblasts and endothelial cells, but the function of IGFBP-5 in cellular senescence is unknown. Here we show that IGFBP-5 plays important roles in the regulation of cellular senescence. Knockdown of IGFBP-5 in old human umbilical endothelial cells (HUVECs) with IGFBP-5 microRNA lentivirus caused partial reduction of a variety of senescent phenotypes, such as changes in cell morphology, increases in cell proliferation and decreases in senescence-associated
-galactosidase (SA-
-gal) staining. In addition, treatment with IGFBP-5 protein or up-regulation of IGFBP-5 in young cells accelerates cellular senescence, as confirmed by cell proliferation and SA-
-gal staining. Premature senescence induced by IGFBP-5 up-regulation in young cells was rescued by knockdown of p53, but not by knockdown of p16. Furthermore, atherosclerotic arteries exhibited strong IGFBP-5-positive staining along intimal plaques. These results suggest that IGFBP-5 plays a role in the regulation of cellular senescence via a p53-dependent pathway and in aging-associated vascular diseases. Keywords: cell aging, IGFBP-5, p53, endothelial cells, atherosclerosis